IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available ...

If someone asked you what you can do with an iPhone, you could say playing games, listening to music, watching videos and even making phone calls. One thing that you probably wouldn't mention is ...

Masimo Corporation MASI recently announced the FDA clearance of its Masimo SET-powered MightySat Medical Pulse Oximeter, available Over-The-Counter (OTC) to consumers without a prescription. This ...

ST. PETERSBURG, Fla. & IRVINE, Calif.--(BUSINESS WIRE)--The Women’s Tennis Association (WTA) and Masimo (NASDAQ: MASI) announced today that the WTA’s Sport Sciences and Medicine (SS&M) team will ...

Medical device creator Masimo announced today its latest 510(k) clearance from the U.S. Food and Drug Administration for the Rad-G pulse oximeter. The Rad-G is a handheld device that combines Masimo’s ...

Amid its multi-front legal battle with Apple over its smartwatch’s blood oxygen sensors, Masimo has claimed new ...

Eliminating racial bias in pulse oximetry has been top of mind lately for many devicemakers and healthcare providers, as well as the FDA, which convened an advisory committee meeting earlier this ...

A federal jury in California said on Friday that Apple owes medical-monitoring technology company Masimo $634 million for ...

A federal jury in California sided with medical tech company Masimo in its suit alleging that the Apple Watch infringed on its patent covering low-power pulse oximeter features. The victory hinged on ...

Apple said the single patent at issue in the case expired in 2022 “and is specific to historic patient monitoring technology ...

Joe Kiani, Founder and CEO of Masimo, said, “Until now, consumers and even healthcare providers had no way of knowing what pulse oximeter they could trust to use at home. On the internet and even in ...